Journals / Joint diseases and related surgery / 2020 / Cilt: 31 - Sayı: 2

Use of cement combined grafting in upper and lower extremity benign bone tumors

Pages
335–340
Publication Date
2022-10-19
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

MSTS scores were significantly worse with the usage of prophylactic fixation (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: This study aims to investigate the effectivity of cement combined demineralized bone matrix (DBM) treatment on new bone formation in the cortical window as well as to evaluate the effect of new bone formation on functional outcomes.Patients and methods: Thirty-two benign bone tumor patients (15 males, 17 females; median age 38 years; range, 12 to 68 years), who were treated with cement combined DBM between February 2010 and December 2014, were evaluated retrospectively.
📊
Key Findings & Data:Patient characteristics were recorded as age, gender, tumor localization, histological diagnosis, Enneking stage, tumor size, size of the cortical window, usage of prophylactic fixation, time to return to work, Musculoskeletal Tumor Society (MSTS) functional score, tumor relapse, and new bone formation on the cortical window in the computed tomography scans after one year of surgery.Results: Mediantumorvolumewas17.2cm3(range, 2.8 to 139.6 cm3), median area of the cortical window was 8.3 cm2 (range, 1.6 to 28.4 cm2), and median postoperative one-year MSTS score was 84.5 (range, 66 to 97).
💡
Conclusion & Impact:MSTS scores were significantly worse with the usage of prophylactic fixation (p
🔬Design:Research Article
📍Scope:2010 Verileri
⚙️Variables:Domain Parameters

Abstract

Objectives: This study aims to investigate the effectivity of cement combined demineralized bone matrix (DBM) treatment on new bone formation in the cortical window as well as to evaluate the effect of new bone formation on functional outcomes.Patients and methods: Thirty-two benign bone tumor patients (15 males, 17 females; median age 38 years; range, 12 to 68 years), who were treated with cement combined DBM between February 2010 and December 2014, were evaluated retrospectively. Patient characteristics were recorded as age, gender, tumor localization, histological diagnosis, Enneking stage, tumor size, size of the cortical window, usage of prophylactic fixation, time to return to work, Musculoskeletal Tumor Society (MSTS) functional score, tumor relapse, and new bone formation on the cortical window in the computed tomography scans after one year of surgery.Results: Mediantumorvolumewas17.2cm3(range, 2.8 to 139.6 cm3), median area of the cortical window was 8.3 cm2 (range, 1.6 to 28.4 cm2), and median postoperative one-year MSTS score was 84.5 (range, 66 to 97). MSTS scores were significantly worse with the usage of prophylactic fixation (p

🔖

Cite This Article

TOKDEMİR, S., UÇAN, V., ELMALI, N., PULATKAN, A., GÜRKAN, V. (2022). Use of cement combined grafting in upper and lower extremity benign bone tumors. Joint diseases and related surgery, Cilt: 31 - Sayı: 2, 335–340. https://ajindex.com/articles/559294

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Nogueira Drumond JM. Benign bone tumors and tumor-like bone lesions: Treatment update and new trends. Rev Bras Ortop 2015;44:386-90
  2. Webb JC, Spencer RF. The role of polymethylmethacrylate bone cement in modern orthopaedic surgery. J Bone Joint Surg [Br] 2007;89:851-7
  3. Hass HJ, Krause H, Kroker S, Wagemann W. Implantation of human demineralized bone matrix (DBM) for the treatment of juvenile bone cysts. Oper Orthop Traumatol 2006;18:19-33
  4. Somville J, De Beuckeleer L, De Schepper A, Verstreken J, Taminiau A. Reliability of measuring volume by different methods for tumors of the musculoskeletal system. Acta Orthop Belg 2001;67:338-43
  5. Enneking WF, Dunham W, Gebhardt MC, Malawar M, Pritchard DJ. A system for the functional evaluation of reconstructive procedures after surgical treatment of tumors of the musculoskeletal system. Clin Orthop Relat Res 1993;286:241-6
  6. Martinez, M, Hwang, J, Beebe KS. Local adjuvants for benign aggressive bone tumors, Current Orthopaedic Practice 2014;25:573-9
  7. Szalay K, Antal I, Kiss J, Szendroi M. Comparison of the degenerative changes in weight-bearing joints following cementing or grafting techniques in giant cell tumour patients: medium-term results. Int Orthop 2006;30:505-9
  8. Özer D, Er T, Aycan OE, Öke R, Coşkun M, KabukçuoğluYS. May bone cement be used to treat benign aggressive bone tumors of the feet with confidence? Foot (Edinb) 2014;24:1-5
  9. Urist MR, Strates BS. Bone formation in implants of partially and wholly demineralized bone matrix. Including observations on acetone-fixed intra and extracellular proteins. Clin Orthop Relat Res 1970;71:271-8
  10. Drosos GI, Touzopoulos P, Ververidis A, Tilkeridis K, Kazakos K. Use of demineralized bone matrix in the extremities. World J Orthop 2015;6:269-77
  11. Dinopoulos H, Dimitriou R, Giannoudis PV. Bone graft substitutes: What are the options? Surgeon 2012;10:230-9
  12. Di Bella C, Dozza B, Frisoni T, Cevolani L, Donati D. Injection of demineralized bone matrix with bone marrow concentrate improves healing in unicameral bone cyst. Clin Orthop Relat Res 2010;468:3047-55
  13. Park IH, Micic ID, Jeon IH. A study of 23 unicameral bone cysts of the calcaneus: open chip allogeneic bone graft versus percutaneous injection of bone powder with autogenous bone marrow. Foot Ankle Int 2008;29:164-70
  14. Kanellopoulos AD, Yiannakopoulos CK, Soucacos PN. Percutaneous reaming of simple bone cysts in children followed by injection of demineralized bone matrix and